In addition to using gemcitabine and the natural killer cells that are TGF-β imprinted, we also are combining an anti-GD2 antibody called naxitamab that's provided by Y-mAbs. Naxitamab, as I said, is ...

If you’re a fan of Notre Dame women’s basketball, you have a chance to contribute to a shirt design while raising money for ...

Older cancer decedents with an implantable cardioverter defibrillator (ICD) receive more aggressive end-of-life care, ...

For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart ...

Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer ...

Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either ...

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have ...

ABC 6 News is continuing the series "Inside the Fight of Breast Cancer" with part four surrounding breast cancer prevention.

After her fight with breast cancer, an area high school girls basketball coach wanted to find a way to help others in their ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...